Prebiotic Ingredients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The prebiotic ingredients market size is projected to expand from USD 6.49 billion in 2025 and USD 7.11 billion in 2026 to USD 11.27 billion by 2031, registering a CAGR of 9.67% between 2026 to 2031. This report is Segmented by Type (Inulin, Fructo-Oligosaccharides, Galacto-Oligosaccharides, and More), Source (Plant-Based, Dairy-Based, Others), Form (Powder, Liquid), Application (Functional Food and Beverage, Infant Formula, and More), and Geography (North America, Europe, Asia-Pacific, South America, and More). The Market Forecasts are Provided in Terms of Both Value (USD) and Volume (Tons).

Global Prebiotic Ingredients Market Trends and Insights

Expansion of the Global Dietary Supplements Market

The dietary supplements industry is expanding at 8.9% annually, and prebiotics are capturing a disproportionate share of formulation budgets as brands pivot from single-strain probiotics to synbiotic blends that combine live cultures with fermentable fibers, according to the Council for Responsible Nutrition. Capsule and tablet formats accounted for 68% of prebiotic supplement sales in 2025, reflecting consumer preference for dosage precision and shelf stability over powders that require reconstitution. Regulatory clarity in the United States, where the FDA granted GRAS status to chicory-root inulin in 2018 and subsequently to galacto-oligosaccharides in 2024, has enabled brands to make structure-function claims without pre-market approval, a streamlined pathway that accelerated product launches by an estimated 14 months compared to novel-food routes in the European Union. E-commerce channels drove 41% of supplement sales in North America in 2025, and direct-to-consumer brands are leveraging prebiotic positioning to differentiate from legacy multivitamin portfolios, with average retail prices for prebiotic-fortified products commanding a 23% premium over non-fortified equivalents. The shift toward personalized nutrition is creating demand for targeted oligosaccharide blends tailored to specific microbiome profiles, a trend that favors ingredient suppliers with analytical capabilities to validate bifidogenic and butyrogenic effects through in vitro fermentation assays.

Rising Demand for Natural and Plant-Based Functional Ingredients

Plant-based sources captured 69.75% of the prebiotic ingredients market in 2025, driven by clean-label mandates from retailers such as Whole Foods Market and Tesco, which require suppliers to disclose extraction solvents and processing aids on technical data sheets. Chicory-root inulin and agave-derived fructans are displacing synthetic fructo-oligosaccharides in premium formulations, as consumers associate botanical origins with lower processing intensity, even though enzymatic synthesis from sucrose can achieve identical molecular structures. Organic certification added USD 0.40 to USD 0.60 per kilogram to ingredient costs in 2025, yet brands targeting Whole30 and paleo demographics absorbed these premiums to maintain positioning. The European Union's Farm to Fork strategy, updated in 2024, set a target for 25% of agricultural land to be under organic management by 2030, a policy that is incentivizing chicory growers in Belgium and the Netherlands to transition acreage and secure long-term contracts with inulin processors. Non-GMO Project verification became a de facto requirement for U.S. market entry in 2025, with 78% of surveyed brands indicating they would not source ingredients lacking third-party verification, a threshold that disadvantages suppliers relying on genetically modified chicory varieties developed for higher inulin yields.

High Production and Processing Costs

Enzymatic synthesis of galacto-oligosaccharides from lactose requires β-galactosidase enzymes sourced from Aspergillus oryzae or Kluyveromyces lactis, inputs that added USD 1.50 to USD 2.20 per kilogram to production costs in 2025, compared to USD 0.80 to USD 1.20 per kilogram for acid-hydrolyzed inulin from chicory root. Downstream purification to remove residual lactose and monosaccharides demands chromatographic separation or nanofiltration, processes that consume 40% to 50% of total manufacturing costs and limit margin expansion for suppliers serving price-sensitive categories such as animal feed and bakery ingredients. Capital expenditure for a greenfield galacto-oligosaccharides plant with 5,000 metric tons annual capacity exceeded USD 18 million in 2025, a threshold that restricts market entry to established dairy cooperatives and specialty-ingredient houses with access to low-cost financing. Energy-intensive spray-drying to convert liquid concentrates into free-flowing powders added USD 0.30 to USD 0.50 per kilogram to production costs in 2025, prompting suppliers to offer liquid formats at discounted prices to beverage manufacturers with in-line dosing systems. Labor costs in Western Europe, where 60% of chicory-inulin production is concentrated, rose by 7.2% between 2024 and 2025, eroding competitiveness relative to emerging suppliers in Thailand and Brazil that benefit from lower wage structures but face quality-perception challenges in premium markets.

Other drivers and restraints analyzed in the detailed report include:

• Increasing Use of Prebiotics in Functional Food and Beverage Products
• Growing Scientific Validation of Microbiome Health Benefits
• Limited Consumer Awareness in Developing Markets

Segment Analysis

Inulin commanded 33.46% of the market in 2025, underpinned by established extraction infrastructure in Belgium, France, and the Netherlands that processes 180,000 metric tons of chicory root annually, yet galacto-oligosaccharides are forecast to expand at 11.59% CAGR through 2031, driven by infant-formula brands seeking EFSA-approved ingredients with documented bifidogenic effects and dairy processors monetizing whey streams through enzymatic conversion. Fructo-oligosaccharides benefit from cost advantages relative to galacto-oligosaccharides and compatibility with high-temperature processing in bakery applications, while mannan-oligosaccharides remain confined to animal-feed applications due to limited human-safety data and the absence of GRAS status in the United States. The "Others" category, encompassing xylo-oligosaccharides and resistant maltodextrin, with growth concentrated in Asia-Pacific markets, where local suppliers offer these variants at 20% to 30% discounts relative to imported inulin.

Regulatory dynamics are reshaping type preferences, as the European Food Safety Authority's 2025 rejection of health-claim applications for mannan-oligosaccharides redirected research and development investment toward galacto-oligosaccharides and fructo-oligosaccharides with established dossiers, a shift that correlates with a 14% decline in mannan-oligosaccharide patent filings between 2024 and 2025. Inulin's dominance is sustained by its dual functionality as a fat replacer and fiber source, attributes that enable formulators to achieve clean-label claims while reducing calorie density in dairy and bakery products. Galacto-oligosaccharides are gaining share in clinical-nutrition formulations targeting elderly populations, as randomized controlled trials published in 2024 demonstrated that daily intake of 8 grams improved bowel regularity and reduced antibiotic-associated diarrhea in hospitalized patients. Fructo-oligosaccharides face headwinds from negative consumer perceptions of "oligosaccharide" terminology, prompting brands to adopt "chicory root fiber" or "prebiotic fiber" on ingredient panels to enhance label appeal.

Plant-based sources held 69.75% of the market in 2025 and are forecast to grow at 10.67% CAGR through 2031, reflecting consumer association of botanical origins with lower processing intensity and alignment with vegan and vegetarian dietary patterns. Chicory root remains the dominant feedstock for inulin extraction, with Belgium and France accounting for 55% of global chicory cultivation in 2025, yet agave and Jerusalem artichoke are emerging as alternative sources that offer geographic diversification and resilience to European drought conditions that reduced chicory yields by 12% in 2024. Dairy-based sources, primarily lactose-derived galacto-oligosaccharides, with growth concentrated in infant-formula applications where regulatory frameworks in the European Union and China mandate ingredients that mirror human-milk oligosaccharide profiles.

The European Union's Farm to Fork strategy, updated in 2024, set a target for 25% of agricultural land to be under organic management by 2030, a policy that is incentivizing chicory growers in Belgium and the Netherlands to transition acreage and secure long-term contracts with inulin processors at premiums of EUR 50 to EUR 80 per metric ton relative to conventional crops, according to the European Commission. Dairy-based galacto-oligosaccharides benefit from vertical integration opportunities, as whey is a low-value byproduct of cheese manufacturing, and enzymatic conversion into prebiotics adds USD 3.50 to USD 5.00 per kilogram of value, transforming a disposal cost into a revenue stream. Non-GMO Project verification became a de facto requirement for U.S. market entry in 2025, with 78% of surveyed brands indicating they would not source ingredients lacking third-party verification, a threshold that disadvantages suppliers relying on genetically modified chicory varieties developed for higher inulin yields. The "Others" category, encompassing seaweed-derived oligosaccharides and fungal sources, accounted for 3% of the market in 2025, with growth constrained by limited production scale and the absence of regulatory approvals in major markets.

Complete Report Scope:

• By Type
  • Inulin
  • Fructo-oligosaccharides (FOS)
  • Galacto-oligosaccharides (GOS)
  • Mannan-oligosaccharides (MOS)
  • Others
• By Source
  • Plant-Based Source
  • Dairy-Based Source
  • Others
• By Form
  • Powder
  • Liquid
• By Application
  • Functional Food and Beverage
  • Infant Formula and Baby Food
  • Dietary Supplements
  • Animal Feed
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Netherlands
    • Poland
    • Belgium
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • Thailand
    • Singapore
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

Europe accounted for 30.58% of the global prebiotics market in 2025, supported by well-established chicory-processing infrastructure in Belgium, France, and the Netherlands, which together supply approximately 55% of global inulin output. Germany represented 22% of European demand in 2025, driven by bakery and dairy manufacturers increasingly incorporating inulin as a fat replacer to meet front-of-pack nutritional targets. In contrast, the United Kingdom recorded a 3.2% contraction between 2024 and 2025, reflecting post-Brexit tariff increases on imported oligosaccharides that elevated ingredient costs by an estimated 8% to 12%. The European Food Safety Authority’s stringent health-claim requirements, particularly the need for randomized controlled trials demonstrating dose-response relationships, continue to create high entry barriers, favoring established ingredients with approved dossiers and concentrating innovation among multinational suppliers with strong regulatory capabilities. Meanwhile, Italy and Spain are emerging as growth pockets, evidenced by an increase in functional beverage launches containing short-chain fructo-oligosaccharides between 2024 and 2025.

Asia-Pacific is forecast to be the fastest-growing region, expanding at an estimated 11.17% CAGR through 2031. Growth is underpinned by infant-formula premiumization in China, where the approval of six new galacto-oligosaccharide suppliers in 2024 intensified competition and reduced ingredient prices by 15% to 18%, enabling broader inclusion of prebiotics at clinically relevant dosages. India’s regulatory environment has also become more supportive following the Food Safety and Standards Authority’s 2024 update permitting structure-function claims for clinically validated prebiotics, accelerating product registrations by approximately 40% and attracting investment from global ingredient suppliers. Japan with growth concentrated in elderly-nutrition products targeting sarcopenia and immune health. Similar demographic-driven trends are emerging in South Korea and Taiwan. Australia recorded 12.3% growth between 2024 and 2025, largely driven by e-commerce expansion and wellness-focused marketing, although regulatory constraints continue to limit explicit on-pack claims. Southeast Asian markets, including Indonesia, Thailand, and Vietnam, remain underpenetrated, with consumer awareness below 25% in 2025, yet rising incomes and expanding modern retail channels are creating long-term opportunities for education-led brand strategies.

North America with the United States is being driven by dietary supplement manufacturers incorporating prebiotics into synbiotic formulations designed to enhance microbiome modulation. The U.S. Food and Drug Administration’s 2024 revision to the dietary fiber definition, recognizing non-digestible carbohydrates with demonstrated physiological benefits, has enabled stronger front-of-pack fiber claims and is associated with higher consumer purchase intent. Canada expanded by 9.8% between 2024 and 2025 following Health Canada’s approval of four new prebiotic health claims linked to bowel function and mineral absorption, supporting differentiation across dairy and cereal categories. Mexico represented 12% of regional demand, with growth centered on functional beverages featuring agave-derived fructans. South America led by Brazil, primarily driven by dairy applications aligned with public health initiatives. Argentina and Chile recorded strong momentum following regulatory approvals and innovation subsidies, although consumer awareness remains a limiting factor. The Middle East and Africa demand is concentrated in the United Arab Emirates, Saudi Arabia, and Turkey. While awareness levels remain low in several African markets, expanding middle-class populations and rising healthcare expenditures indicate favorable long-term growth prospects.

List of Companies Covered in this Report:

• Tereos S.A.
• Ingredion Incorporated
• Archer Daniels Midland Company
• Cargill Incorporated
• International Flavors & Fragrances Inc.
• Cosun Beet Company (Sensus B.V.)
• Kerry Group plc
• Cosucra Groupe Warcoing S.A.
• Roquette Frères S.A.
• Samyang Corporation
• Clasado Biosciences Ltd.
• AIDP Inc.
• Chr. Hansen A/S
• DSM-firmenich
• Südzucker Group
• Royal FrieslandCampina N.V.
• Nexira A/S
• Bunge Limited
• Prenexus Health
• Beghin Meiji S.A.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support